TY - JOUR
AU - D. F. Haley
AU - E. R. Agoos
AU - C. R. Yarbrough
AU - L. W. Suen
AU - L. Beletsky
A1 - 
AD - From the Department of Community Health Sciences, Boston University School of Public Health, Boston, MA (DFH, ERA); Department of Health Policy and Management, Rollins School of Public Health, Emory University, Atlanta, GA (CRY); Division of General Internal Medicine at Zuckerberg San Francisco General Hospital, Department of Medicine, University of California San Francisco, San Francisco, CA (LWS); School of Law, Northeastern University, Boston, MA (LB); Department of Health Sciences, Bouve College of Health Sciences, Northeastern University, Boston, MA (LB); and Health in Justice Action Lab, Northeastern University, Boston, MA (LB).
AN - 38126704
BT - J Addict Med
C5 - Opioids & Substance Use; HIT & Telehealth
CP - 1
DA - Jan-Feb 01
DO - 10.1097/adm.0000000000001255
DP - NLM
ET - 20231221
IS - 1
JF - J Addict Med
LA - eng
PY - 2024
SN - 1932-0620 (Print); 1932-0620
SP - 78
EP - 81+
ST - Missed Opportunities: Substance Use Hotline Operator Uncertainty of State Buprenorphine Prescribing via Telemedicine
T1 - Missed Opportunities: Substance Use Hotline Operator Uncertainty of State Buprenorphine Prescribing via Telemedicine
T2 - J Addict Med
TI - Missed Opportunities: Substance Use Hotline Operator Uncertainty of State Buprenorphine Prescribing via Telemedicine
U1 - Opioids & Substance Use; HIT & Telehealth
U3 - 10.1097/adm.0000000000001255
VL - 18
VO - 1932-0620 (Print); 1932-0620
Y1 - 2024
ER -